StockData
Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc. (CODX) stock

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.28−0.01 (-3.78%)

Close on Nov 11, 2026Market cap $1.74MP/E –Yield –

Co-Diagnostics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Co-Diagnostics's price to book ratio was 0.1× on Nov 11, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.1× to 2.6×, with a median of 0.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.1×−0.1
2025Dec 31, 20250.2×−0.2
2024Dec 31, 20240.4×−0.0
2023Dec 29, 20230.4×−0.2
2022Dec 30, 20220.6×−2.0
2021Dec 31, 20212.6×−2.4
2020Dec 31, 20205.0×+0.3
2019Dec 31, 20194.7×−143.5
2018Dec 31, 2018148.2×+141.9
2017Dec 29, 20176.2×–

More Co-Diagnostics figures

See a number that looks wrong?